| INCYTE DL-,001 | 64.94 / +1.18% |
| Date/Time | 03/29 / 22:58 |
| Chg. / Chg.(%) | 0.76 / +1.18% |
| Bid | 64.94 |
| Ask | 66.26 |
| Open | 64.22 |
| Previous Close | 64.18 |
| High | 65.63 |
| Low | 64.22 |
| Volume [EUR] | - |
| Volume [Units] | |
| Price fixings | 13663 |
| ISIN | US45337C1027 |
| Security | ICY |
| Exchange | Lang & Schwarz |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| NASDAQ | 71.1400 |  |
953,620 |
| IEX | 71.14 | |
36,772 |
| Cboe US | 71.14 | |
27,894 |
| Frankfurt | 64.9100 |  |
200 |
| TradeGate | 65.550 | |
50 |
| Hannover | 65.15 | |
0 |
| München | 65.49 | |
0 |
| Düsseldorf | 65.14 | |
0 |
| Berlin | 65.43 | |
0 |
| Stuttgart | 64.960 | |
0 |
| Lang & Schwa.. | 64.94 | |
|
| Quotrix | 65.2300 | |
|
| gettex | 65.430 | |
|
| London Domes.. | 72.26 | 3,019 |
News
- Wall Street back to losses, Dow slides 200 points
02/07/2023 / 19:53 - TeleTrader - US markets lower amid economic data, Fed's Powell
02/07/2023 / 15:30 - TeleTrader - RECELL® System Vitiligo Clinical Trial Protocol to be Presented at the Global Vitiligo Foundation Annual Scientific Symposium
03/23/2022 / 21:01 - GlobeNewswire - STRATA Skin Sciences Names John Bagdasarian as Vice President of Professional Relations
03/14/2022 / 21:05 - GlobeNewswire - Actuate Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of Elraglusib Plus Retifanlimab as Investigational First Line Therapy for Patients With Advanced Pancreatic Cancer
03/01/2022 / 13:55 - GlobeNewswire
Personal area
Real-timeClick on 
to activate push quotes.
to activate push quotes.